Greenspring Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Greenspring Advisors's LLY Position: Q2 2026 in Review
Greenspring Advisors increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $65.4K and bringing the position to 3,171 shares worth $3.8M. The position accounts for 0.21% of the portfolio, ranked #65.
Greenspring Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Greenspring Advisors held 3,171 shares of Eli Lilly worth $3.8M as of Q2 2026.
- Greenspring Advisors bought 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
- Eli Lilly made up 0.21% of Greenspring Advisors's portfolio in Q2 2026, its #65 holding.
- Greenspring Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Greenspring Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.